American Journal of Nephrology · 2010 · 34 citations · 8 references
MedicineNephrologySurgeryKidney TransplantationTransplant ImmunologyTransplant SurgeryAcute RejectionAllograft RejectionAllograft VasculopathyGraft RejectionImmunosuppression In Kidney TransplantationTransplant RejectionComplement System AbnormalitiesCytomegalovirus DiseaseHumoral RejectionInfection After TransplantationKidney Transplant RecurrenceOrgan Ischemia-reperfusion InjuryPost-transplant Cytomegalovirus InfectionTransplant-associated Thrombotic Microangiopathy
After kidney transplantation, thrombotic microangiopathy (TMA) can occur de novo or as recurrent disease. Risk factors for de novo posttransplant TMA include ischemia-reperfusion injury, immunosuppressive drugs, viral infections, acute humoral rejection, and complement gene abnormalities. Cytomegalovirus infection as a trigger for posttransplant TMA in kidney transplant recipients has only been reported in 7 cases, all of them between 4 weeks and 8 years after transplantation. We describe a new case of de novo TMA in association with cytomegalovirus infection 25 years after kidney transplantation.
8
Thrombotic Microangiopathy After Kidney Transplantation
Marina Noris, Giuseppe Remuzzi · American Journal of Transplantation · 2010 · 213 citations
Medicine, Nephrology, Surgery +14
Post-transplant hemolytic-uremic syndrome
Piero Ruggenenti · Kidney International · 2002 · 77 citations